PA173080
Hepatitis B Virus Surface Ad/Ay Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PA173080-Each-of-1 | In Stock | ₹ 46,324.50 |
PA173080 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,324.50
GST (18%): ₹ 8,338.41
Total Price: ₹ 54,662.91
Antigen
Hepatitis B Virus Surface Ad/Ay
Classification
Polyclonal
Conjugate
Unconjugated
Gene Alias
HBsAg; HBV; hepatitis b virus surface antigen; HepB
Immunogen
Surface antigen subtypes ad & ay.
Quantity
1 mL
Primary or Secondary
Primary
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Applications
ELISA
Concentration
4-5 mg/mL
Formulation
PBS with 0.1% sodium azide, pH 7.2
Host Species
Goat
Purification Method
IgG fraction
Regulatory Status
RUO
Target Species
Virus
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Description The PA1-73080 antibody reacts with Hepatitis B surface antigen
- PA1-73080 has been successfully used in ELISA applications
- The PA1-73080 antibody was raised against the surface antigen subtypes ad & ay
- The hepatitis B virus is an important cause of acute and chronic liver disease
- It is also the most common form of parenterally transmitted viral hepatitis
- The HBV surface protein antigens (HBsAg) are comprised of three carboxyl co terminal HBs proteins termed large (LHBs), middle (MHBs) and small (SHBs, also called major) protein
- LHBs and MHBs also share the highly hydrophobic, repetitive, membrane spanning S domain
- In addition, MHBs has a 55 amino acid region called preS2
- The virus is estimated to affect some 350 million people worldwide
- Immunization against hepatitis B is an important component of preventative medicine and is offered to all children in approximately 30 countries
- Hepatitis B virus (HBV) belongs to the Hepadnaviridae family and infection with HBV is usually more serious than infection with hepatitis A virus
- In some individuals the infection is not cleared and followed by persistent intracellular viral carriage that can lead to the development of hepatocelular carcinomas
- There are currently 400 million HBV carriers worldwide making HBV one of the most common human pathogens.